These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38452984)

  • 1. An autophagy-associated diagnostic signature based on peripheral blood for antibody-mediated rejection in renal transplantation.
    Xu Y; Wang Y; Zhang D; Zhang H; Wang Y; Wang W; Hu X
    Transpl Immunol; 2024 Jun; 84():102021. PubMed ID: 38452984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disappearance of T Cell-Mediated Rejection Despite Continued Antibody-Mediated Rejection in Late Kidney Transplant Recipients.
    Halloran PF; Chang J; Famulski K; Hidalgo LG; Salazar ID; Merino Lopez M; Matas A; Picton M; de Freitas D; Bromberg J; Serón D; Sellarés J; Einecke G; Reeve J
    J Am Soc Nephrol; 2015 Jul; 26(7):1711-20. PubMed ID: 25377077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural killer cell infiltration is discriminative for antibody-mediated rejection and predicts outcome after kidney transplantation.
    Yazdani S; Callemeyn J; Gazut S; Lerut E; de Loor H; Wevers M; Heylen L; Saison C; Koenig A; Thaunat O; Thorrez L; Kuypers D; Sprangers B; Noël LH; Van Lommel L; Schuit F; Essig M; Gwinner W; Anglicheau D; Marquet P; Naesens M
    Kidney Int; 2019 Jan; 95(1):188-198. PubMed ID: 30396694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies.
    Haas M; Mirocha J; Reinsmoen NL; Vo AA; Choi J; Kahwaji JM; Peng A; Villicana R; Jordan SC
    Kidney Int; 2017 Mar; 91(3):729-737. PubMed ID: 28104301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The regulation of interferon type I pathway-related genes RSAD2 and ETV7 specifically indicates antibody-mediated rejection after kidney transplantation.
    Matz M; Heinrich F; Zhang Q; Lorkowski C; Seelow E; Wu K; Lachmann N; Addo RK; Durek P; Mashreghi MF; Budde K
    Clin Transplant; 2018 Dec; 32(12):e13429. PubMed ID: 30341925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and Functional Noninvasive Immune Monitoring in the ESCAPE Study for Prediction of Subclinical Renal Allograft Rejection.
    Crespo E; Roedder S; Sigdel T; Hsieh SC; Luque S; Cruzado JM; Tran TQ; Grinyó JM; Sarwal MM; Bestard O
    Transplantation; 2017 Jun; 101(6):1400-1409. PubMed ID: 27362314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts.
    Loupy A; Vernerey D; Tinel C; Aubert O; Duong van Huyen JP; Rabant M; Verine J; Nochy D; Empana JP; Martinez F; Glotz D; Jouven X; Legendre C; Lefaucheur C
    J Am Soc Nephrol; 2015 Jul; 26(7):1721-31. PubMed ID: 25556173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptomic signatures of chronic active antibody-mediated rejection deciphered by RNA sequencing of human kidney allografts.
    Shah Y; Yang H; Mueller FB; Li C; Gul Rahim SE; Varma E; Salinas T; Dadhania DM; Salvatore SP; Seshan SV; Sharma VK; Elemento O; Suthanthiran M; Muthukumar T
    Kidney Int; 2024 Feb; 105(2):347-363. PubMed ID: 38040290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Probabilistic Approach to Histologic Diagnosis of Antibody-Mediated Rejection in Kidney Transplant Biopsies.
    Halloran PF; Famulski KS; Chang J
    Am J Transplant; 2017 Jan; 17(1):129-139. PubMed ID: 27340822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of monitoring circulating donor-reactive memory B cells to characterize antibody-mediated rejection after kidney transplantation.
    Luque S; Lúcia M; Melilli E; Lefaucheur C; Crespo M; Loupy A; Bernal-Casas D; Gomà M; Jarque M; Crespo E; Montero N; Manonelles A; Cruzado JM; Gil-Vernet S; Grinyó JM; Bestard O
    Am J Transplant; 2019 Feb; 19(2):368-380. PubMed ID: 30085394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genes associated with antibody-dependent cell activation are overexpressed in renal biopsies from patients with antibody-mediated rejection.
    Suviolahti E; Ge S; Nast CC; Mirocha J; Karasyov A; White M; Jordan SC; Toyoda M
    Transpl Immunol; 2015 Jan; 32(1):9-17. PubMed ID: 25449536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the Banff 2013 classification on the diagnosis of suspicious versus conclusive late antibody-mediated rejection in allografts without acute dysfunction.
    Gimeno J; Redondo D; Pérez-Sáez MJ; Naranjo-Hans D; Pascual J; Crespo M
    Nephrol Dial Transplant; 2016 Nov; 31(11):1938-1946. PubMed ID: 27312147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic Active Antibody-Mediated Rejection Is Associated With the Upregulation of Interstitial But Not Glomerular Transcripts.
    Trailin A; Mrazova P; Hruba P; Voska L; Sticova E; Slavcev A; Novotny M; Kocik M; Viklicky O
    Front Immunol; 2021; 12():729558. PubMed ID: 34616398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor-Specific Antibody Is Associated with Increased Expression of Rejection Transcripts in Renal Transplant Biopsies Classified as No Rejection.
    Madill-Thomsen KS; Böhmig GA; Bromberg J; Einecke G; Eskandary F; Gupta G; Hidalgo LG; Myslak M; Viklicky O; Perkowska-Ptasinska A; Halloran PF;
    J Am Soc Nephrol; 2021 Nov; 32(11):2743-2758. PubMed ID: 34253587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-mediated rejection in the Banff classifications of 2007 and 2017: A comparison of renal graft loss prediction capability.
    Solar-Cafaggi D; Marino L; Uribe-Uribe N; Morales-Buenrostro LE
    Transpl Immunol; 2018 Dec; 51():40-44. PubMed ID: 30170180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Performance of Donor-Derived Plasma Cell-Free DNA Fraction for Antibody-Mediated Rejection in Post Renal Transplant Recipients: A Prospective Observational Study.
    Zhang H; Zheng C; Li X; Fu Q; Li J; Su Q; Zeng L; Liu Z; Wang J; Huang H; Xu B; Ye M; Liu L; Wang C
    Front Immunol; 2020; 11():342. PubMed ID: 32184785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Analysis of Transcript Changes Associated With Allograft Rejection: Combining Universal and Selective Features.
    Halloran PF; Venner JM; Famulski KS
    Am J Transplant; 2017 Jul; 17(7):1754-1769. PubMed ID: 28101959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Trifecta Study: Comparing Plasma Levels of Donor-derived Cell-Free DNA with the Molecular Phenotype of Kidney Transplant Biopsies.
    Halloran PF; Reeve J; Madill-Thomsen KS; Demko Z; Prewett A; Billings P;
    J Am Soc Nephrol; 2022 Feb; 33(2):387-400. PubMed ID: 35058354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microarray diagnosis of antibody-mediated rejection in kidney transplant biopsies: an international prospective study (INTERCOM).
    Halloran PF; Pereira AB; Chang J; Matas A; Picton M; De Freitas D; Bromberg J; Serón D; Sellarés J; Einecke G; Reeve J
    Am J Transplant; 2013 Nov; 13(11):2865-74. PubMed ID: 24119109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary C-X-C Motif Chemokine 10 Independently Improves the Noninvasive Diagnosis of Antibody-Mediated Kidney Allograft Rejection.
    Rabant M; Amrouche L; Lebreton X; Aulagnon F; Benon A; Sauvaget V; Bonifay R; Morin L; Scemla A; Delville M; Martinez F; Timsit MO; Duong Van Huyen JP; Legendre C; Terzi F; Anglicheau D
    J Am Soc Nephrol; 2015 Nov; 26(11):2840-51. PubMed ID: 25948873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.